[The experience of using cellex in treatment of patients with acute ischemic stroke].

Aim: To evaluate the efficacy and safety of the combination of cellex with basic therapy in patients with ischemic stroke in the acute stage.

Material And Methods: An analytical prospective, randomized, simple, blind study included 52 patients with ischemic stroke. The main group of patients (n=26) was treated with basic therapy, which included hypotensive drugs, antiaggregants or anticoagulants depending on the concomitant pathology as well as vascular medications.